2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
The rational design of H102-CP05, a 22-residue chimeric peptide that integrates the β-sheet breaker peptide H102 with the CD63-targeting anchor CP05 to enable extracellular vesicle (EV) delivery of an Aβ-inhibitory payload is reported, supporting H102-CP05 as a promising EV-displayed therapeutic candidate for AD.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
